ICU Medical, Inc. (NASDAQ:ICUI) Stock Holdings Raised by Cinctive Capital Management LP

Cinctive Capital Management LP grew its stake in ICU Medical, Inc. (NASDAQ:ICUI) by 91.4% during the fourth quarter, HoldingsChannel.com reports. The firm owned 50,149 shares of the medical instruments supplier’s stock after purchasing an additional 23,954 shares during the period. Cinctive Capital Management LP’s holdings in ICU Medical were worth $7,782,000 as of its most recent SEC filing.

Several other large investors have also modified their holdings of the stock. Harvest Fund Management Co. Ltd acquired a new stake in ICU Medical during the fourth quarter valued at approximately $33,000. Murphy & Mullick Capital Management Corp bought a new stake in shares of ICU Medical in the 4th quarter valued at approximately $52,000. Point72 Hong Kong Ltd acquired a new stake in shares of ICU Medical during the 3rd quarter valued at approximately $72,000. Venturi Wealth Management LLC lifted its stake in ICU Medical by 64.0% during the fourth quarter. Venturi Wealth Management LLC now owns 528 shares of the medical instruments supplier’s stock worth $82,000 after purchasing an additional 206 shares during the last quarter. Finally, Smartleaf Asset Management LLC lifted its stake in ICU Medical by 166.8% during the fourth quarter. Smartleaf Asset Management LLC now owns 907 shares of the medical instruments supplier’s stock worth $140,000 after purchasing an additional 567 shares during the last quarter. Institutional investors own 96.10% of the company’s stock.

Insiders Place Their Bets

In other ICU Medical news, CEO Vivek Jain sold 1,373 shares of the business’s stock in a transaction dated Thursday, January 2nd. The shares were sold at an average price of $155.48, for a total transaction of $213,474.04. Following the sale, the chief executive officer now directly owns 104,593 shares in the company, valued at approximately $16,262,119.64. The trade was a 1.30 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 6.70% of the stock is currently owned by insiders.

ICU Medical Stock Performance

ICUI stock opened at $137.80 on Wednesday. The stock’s fifty day moving average is $153.34 and its two-hundred day moving average is $163.24. The stock has a market capitalization of $3.38 billion, a price-to-earnings ratio of -30.15 and a beta of 0.73. The company has a debt-to-equity ratio of 0.75, a quick ratio of 1.03 and a current ratio of 2.29. ICU Medical, Inc. has a 1 year low of $93.36 and a 1 year high of $196.26.

Wall Street Analyst Weigh In

Several research firms have weighed in on ICUI. Jefferies Financial Group upgraded shares of ICU Medical from a “hold” rating to a “buy” rating and set a $200.00 target price for the company in a research note on Wednesday, December 11th. StockNews.com downgraded shares of ICU Medical from a “buy” rating to a “hold” rating in a research report on Thursday, March 27th. Finally, Raymond James set a $97.00 price objective on shares of ICU Medical in a research note on Wednesday, March 12th. Two research analysts have rated the stock with a hold rating, two have given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $168.67.

ICU Medical Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.